The purpose of this study is to evaluate a new test being developed by Tempus for patients with Non-Small Cell Lung Cancer (NSCLC). The goal of this new test is to predict the likelihood of a patient's cancer coming back after treatment, and to further explore changes in patient's tumors throughout treatment to see how they respond.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Jason Akulian
Medicine-Pulmonary
Clinical or Medical
Observational
Cancer (Lung)
Lungs and Breathing
23-0793
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
